Cerus Corporation Receivables Turnover Ratio (CERS), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Cerus Corporation  (NASDAQ: CERS)
 

Cerus Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Cerus Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 7.48, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Cerus in Sep 30 2026 quarter, has decreased to 49 days, compared to 50 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 204 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 925 to 1848.

What is Receivable Turnover Ratio?
What is Cerus Corporation Selling?


What is Receivable Turnover Ratio?





CERS Receivables Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Receivable Change 2.65 % -1.33 % 11.3 % 2 % 22.21 %
Y / Y Revenue Change 10.69 % 10.52 % 24.68 % 14.33 % 15.36 %
Receivable Turnover Ratio (TTM) 7.48 7.35 7.14 6.97 6.75
CERS's Total Ranking # 1848 # 925 # 629 # 1841 #
Accounts Receivable average collection period days 49 50 51 52 54
Seq. Receivable Change -1.34 % 5.64 % -3.46 % 2.02 % -5.17 %
Seq. Revenue Change 0.48 % 8.6 % -9.97 % 12.68 % 0.32 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 71
Healthcare Sector # 205
Overall Market # 1848

Receivable Turnover Ratio Statistics
High Average Low
9.98 7.64 4.85
(Dec 31 2022)   (Sep 30 2017)






Financial Statements
Cerus's Accounts Receivable $ 31 Millions Visit CERS's Balance sheet
Cerus's Sales TTM $ 227 Millions Visit CERS's Income Statement
Sources of CERS's Revenues Visit CERS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CERS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CERS's Growth Rates CERS's Roa CERS's Inventory Turnover Ratio CERS's Dividend Comparisons
CERS's Profitability Ratios CERS's Roi CERS's Asset Turnover Ratio CERS's Dividend Growth
CERS's Valuation Ratios CERS's Roe CERS's Financial Strength Ratios CERS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Biogen Inc   15.19 $ 10,297.300  Millions$ 677.900  Millions
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Pediatrix Medical Group Inc   8.57 $ 1,959.124  Millions$ 228.471  Millions
Tenet Healthcare Corp  8.54 $ 22,154.000  Millions$ 2,593.250  Millions
Brightspring Health Services Inc   8.50 $ 9,479.144  Millions$ 1,114.763  Millions
Tactile Systems Technology Inc   8.23 $ 357.176  Millions$ 43.385  Millions
Penumbra Inc  8.22 $ 1,560.334  Millions$ 189.735  Millions
Inspire Medical Systems inc   8.15 $ 882.194  Millions$ 108.207  Millions
Alphatec Holdings Inc   7.91 $ 839.652  Millions$ 106.153  Millions
Exelixis Inc   7.89 $ 2,496.861  Millions$ 316.636  Millions
Idexx Laboratories Inc  7.78 $ 4,663.675  Millions$ 599.701  Millions
Merit Medical Systems Inc  7.53 $ 1,612.236  Millions$ 214.065  Millions
Cerus Corporation  7.48 $ 226.798  Millions$ 30.308  Millions
Insmed Inc  7.45 $ 1,479.040  Millions$ 198.502  Millions
Novocure Limited  7.44 $ 725.388  Millions$ 97.525  Millions
Intuitive Surgical Inc   7.44 $ 12,115.600  Millions$ 1,629.350  Millions
Quest Diagnostics Inc  7.43 $ 11,841.000  Millions$ 1,593.250  Millions
Travere Therapeutics Inc   7.32 $ 651.034  Millions$ 88.900  Millions
Aurinia Pharmaceuticals Inc   7.18 $ 321.738  Millions$ 44.795  Millions
Beta Bionics Inc   7.15 $ 127.899  Millions$ 17.897  Millions
Angiodynamics Inc   7.13 $ 323.784  Millions$ 45.418  Millions
Stryker Corp  6.99 $ 26,300.000  Millions$ 3,761.500  Millions
Boston Scientific Corporation  6.96 $ 21,070.000  Millions$ 3,028.750  Millions
Syndax Pharmaceuticals Inc   6.89 $ 289.431  Millions$ 42.011  Millions

Date modified: 2026-11-03T09:56:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.